Biotech Sebacia scores $26M in venture capital to treat acne

Sebacia Inc., which is based in Duluth, Ga., is developing a topical formulation that uses laser-activated microparticles to treat moderate to severe acne. Sebacia intends to use the Series D financing to complete a U.S. pivotal trial.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news